Analysis of Inpatient Care Utilization Among Type 2 Diabetes Mellitus Patients
DOI:
https://doi.org/10.47701/zh1qzk63Keywords:
Utilization, diabetes mellitus, T2DM, National Health Insurance, BPJS KesehatanAbstract
Globally and in Indonesia, diabetes mellitus (DM) is mainly type 2. When outpatient care fails to control blood glucose, hospitalization treatment becomes necessary. This is in line with the implementation of the referral system in the era of the National Health Insurance. This study aims to analyze the utilization of hospitalization among patients diagnosed with Type 2 DM (T2DM). A cross-sectional design was applied using sample data from BPJS Kesehatan Year 2024, representing 2023 visit records. All patients admitted with T2DM were included. Inpatient utilization measured by admission frequency, intervals, length of stay, referral sources, diagnostic consistency, discharge status, and comorbidities among T2DM patients. Descriptive analysis was performed on patient characteristics and hospitalization utilization patterns. In 2023, there were 480 admissions involving 417 patients, mean interval between hospitalizations was 69 days. The length of hospital stay increased with the presence of complications. Most referrals came from hospitals, 66% of primary diagnoses matched the admission diagnosis, and hypertension was the most common comorbidity. Most discharge status was recovered. Recommendations include enhancing continuity of care and the referral back program through system integration to mitigate T2DM readmission risks.
Downloads
References
1. Sanches JM, Zhao LN, Salehi A, Wollheim CB, Kaldis P. Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk. FEBS Journal. 2023 Feb 1;290(3):620–48.
2. Sapra A, Bhandari P. Diabetes [Internet]. StatPearls. StatPearls; 2023 [cited 2025 Oct 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551501/
3. Mahmud FR, Sudirman S, Afni N. Faktor-Faktor Yang Berhubungan Dengan Penyakit Diabetes Melitus Di Ruang Poli Interna Rsud Mokopido Kabupaten Tolitoli. Jurnal Kolaboratif Sains. 2018;1(1):168–75.
4. Kemenkes RI. Kepmenkes RI No. HK.01.07/MENKES/1645/2024 tentang Rujuk Balik Penyakit Kronis ke Fasilitas Kesehatan Tingkat Pertama. 2024.
5. International Diabetes Federation. Diabetes around the world in 2021 [Internet]. 2021 [cited 2023 Mar 10]. Available from: https://diabetesatlas.org/regional-factsheets/
6. International Diabetes Federation. IDF Diabetes Atlas 10th edition [Internet]. 2021. Available from: www.diabetesatlas.org
7. Dweib M, El Sharif N. Diabetes-Related Microvascular Complications in Primary Health Care Settings in the West Bank, Palestine. J Clin Med. 2023 Nov 1;12(21).
8. Soewondo P, Ferrario A, Levenus Tahapary D. Challenges in diabetes management in Indonesia: a literature review [Internet]. 2013. Available from: http://www.globalizationandhealth.com/content/9/1/63
9. Trusda SAD, Purbaningsih W, Budiman B, Fitriadi SSN. Characteristics of Patients with Type 2 Diabetes Mellitus in Al-Ihsan Regional General Hospital. Global Medical and Health Communication (GMHC). 2021 Aug 29;9(2).
10. Iglay K, Hannachi H, Joseph Howie P, Xu J, Li X, Engel SS, et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016 Jul 2;32(7):1243–52.
11. Kemenkes. PERMENKES No. 16 Tahun 2024 tentang Sistem Rujukan Pelayanan Kesehatan Perorangan. 2024.
12. Milita F, Handayani S, Setiaji B. Kejadian Diabetes Mellitus Tipe II pada Lanjut Usia di Indonesia (Analisis Riskesdas 2018). Jurnal Kedokteran dan Kesehatan [Internet]. 2021 Jan;17(1). Available from: https://jurnal.umj.ac.id/index.php/JKK
13. Obaid HA, Marques-Vidal P. Trends in diabetes mellitus and related costs among hospital admissions in Switzerland, 2012–2020. Diabetology and Metabolic Syndrome . 2025 Dec 1;17(1).
14. DJSN. Laporan Tahunan JKN Tahun 2024. 2024.
15. Hidayat B, Ramadani RV, Rudijanto A, Soewondo P, Suastika K, Siu Ng JY. Direct Medical Cost of Type 2 Diabetes Mellitus and Its Associated Complications in Indonesia. Value Health Reg Issues. 2022 Mar 1;28:82–9.
16. England Terminology N, Delivery Service C. National Clinical Coding Standards ICD-10 5 th Edition for Morbidity Coding Accurate data for quality information [Internet]. 2024. Available from: http://systems.digital.nhs.uk/data/clinicalcoding
17. Firman, Lestari K. Analisis Pembiayaan berdasarkan Lama Rawat Pasien BPJS Diabetes Melitus Tipe II Komplikasi Sirkulasi Perifer di RSU PKU Muhammadiyah Bantul. Jurnal Ekonomi Kesehatan Indonesia. 2024 Jun 25;9(1).
18. Pranoto B, Retno Intening V, Sudarta IW, Elfrida Sinaga MR. Gambaran Pelaksanaan Sistem Rujukan Pasien BPJS Klinik Pertama di Wonosobo. Stikes Bethesda. 2024 Aug;4.
19. Zhang D, Yan B, He S, Tong S, Huang P, Zhang Q, et al. Diagnostic consistency between admission and discharge of pediatric cases in a tertiary teaching hospital in China. BMC Pediatr. 2023 Dec 1;23(1).
20. Putri S, Yulia N, Indawati L, Rosmala Dewi D. Ketepatan Pengodean Diagnosis dan Tindakan Medis 10 Penyakit Terbanyak. Surya Medika. 2024 Jun;19(2):103–9.
21. Hidayah A, Puspandari DA, Hendrartini Y. Faktor Yang Mempengaruhi Rawat Inap Berulang Pasien JKN di FKRTL Kantor Cabang Semarang Tahun 2021. Jurnal Jaminan Kesehatan Nasional (JJKN). 2022 Dec 5;2(2):239–49.
22. Presiden RI. Perpres No. 59 Tahun 2024 tentang Jaminan Kesehatan. 2024.
23. Ayutthaya SS, Adnan N. Faktor Risiko Hipertensi pada Penderita Diabetes Mellitus Tipe 2. Jurnal Ilmu Kesehatan Masyarakat. 2020 May 24;9(02):60–71.
24. Pradnya AA, Vidiani P, Aditama L, Lorensia A. Kajian Continuity of Care Pasien Program Rujuk Balik di Puskesmas Kota Surabaya [Internet]. Vol. 5, MPI (Media Pharmaceutica Indonesiana )¿. 2023. Available from: https://journal.ubaya.ac.id/index.php/MPI/index
25. Wang YJ, Seggelke S, Hawkins RM, Gibbs J, Lindsay M, Hazlett I, et al. Impact of Glucose Management Team on Outcomes of Hospitalization in Patients With Type 2 Diabetes Admitted to the Medical Service. Endocrine Practice. 2016 Dec;22(12):1401–5.
26. Bansal V, Mottalib A, Pawar TK, Abbasakoor N, Chuang E, Chaudhry A, et al. Inpatient diabetes management by specialized diabetes team versus primary service team in non-critical care units: impact on 30-day readmission rate and hospital cost. BMJ Open Diabetes Res Care. 2018 Apr 5;6(1):e000460.
27. Mandel SR, Langan S, Mathioudakis NN, Sidhaye AR, Bashura H, Bie JY, et al. Retrospective study of inpatient diabetes management service, length of stay and 30-day readmission rate of patients with diabetes at a community hospital. J Community Hosp Intern Med Perspect. 2019 Mar 4;9(2):64–73.
28. Brumm S, Theisen K, Falciglia M. Diabetes Transition Care From an Inpatient to Outpatient Setting in a Veteran Population. Diabetes Educ. 2016 Jun 6;42(3):346–53.
29. Magny-Normilus C, Nolido N V., Borges JC, Brady M, Labonville S, Williams D, et al. Effects of an Intensive Discharge Intervention on Medication Adherence, Glycemic Control, and Readmission Rates in Patients With Type 2 Diabetes. J Patient Saf. 2021 Mar;17(2):73–80.
30. Wright EA, Graham JH, Maeng D, Tusing L, Zaleski L, Martin R, et al. Reductions in 30-day readmission, mortality, and costs with inpatient–to–community pharmacist follow-up. Journal of the American Pharmacists Association. 2019 Mar;59(2):178–86.
31. Rubin DJ, Gogineni P, Deak A, Vaz C, Watts S, Recco D, et al. The Diabetes Transition of Hospital Care (DiaTOHC) Pilot Study: A Randomized Controlled Trial of an Intervention Designed to Reduce Readmission Risk of Adults with Diabetes. J Clin Med. 2022 Mar 8;11(6):1471.
32. Bhalodkar A, Sonmez H, Lesser M, Leung T, Ziskovich K, Inlall D, et al. The Effects of a Comprehensive Multidisciplinary Outpatient Diabetes Program on Hospital Readmission Rates in Patients with Diabetes: A Randomized Controlled Prospective Study. Endocrine Practice. 2020 Nov;26(11):1331–6.
33. Ha NT, Harris M, Preen D, Robinson S, Moorin R. Identifying patterns of general practitioner service utilisation and their relationship with potentially preventable hospitalisations in people with diabetes: The utility of a cluster analysis approach. Diabetes Res Clin Pract. 2018 Apr 1;138:201–10.
34. Khazen M, Abu Ahmad W, Spolter F, Golan-Cohen A, Merzon E, Israel A, et al. Greater temporal regularity of primary care visits was associated with reduced hospitalizations and mortality, even after controlling for continuity of care. BMC Health Serv Res. 2023 Dec 1;23(1).
35. Georgescu V, Green A, Jensen PB, Möller S, Renard E, Mercier G. Primary care visits can reduce the risk of potentially avoidable hospitalizations among persons with diabetes in France. Eur J Public Health. 2020 Dec 1;30(6):1056–61.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Nauri Anggita Temesvari, Husni Abdul Muchlis
This work is licensed under a Creative Commons Attribution 4.0 International License.
